These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36268280)

  • 1. Mining Database to Identify Aging-Related Molecular Subtype and Prognostic Signature in Lung Adenocarcinoma.
    Feng C; Che W; Liang H; Zhang H; Lan C; Wu B; Lin W; Chen Y
    J Oncol; 2022; 2022():9142903. PubMed ID: 36268280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
    Hu J; Wang T; Chen Q
    Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps.
    Zuo Y; Leng G; Leng P
    Pathol Oncol Res; 2023; 29():1610899. PubMed ID: 37143472
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic Value of Genomic Instability of m
    Li R; Li JP; Liu TT; Huo C; Yao J; Ji XL; Qu YQ
    Front Cell Dev Biol; 2022; 10():707405. PubMed ID: 35309906
    [No Abstract]   [Full Text] [Related]  

  • 5. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive bioinformatics analysis to identify a novel cuproptosis-related prognostic signature and its ceRNA regulatory axis and candidate traditional Chinese medicine active ingredients in lung adenocarcinoma.
    Wang S; Xing N; Meng X; Xiang L; Zhang Y
    Front Pharmacol; 2022; 13():971867. PubMed ID: 36110528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Seven-Long Non-coding RNA Signature Improves Prognosis Prediction of Lung Adenocarcinoma: An Integrated Competing Endogenous RNA Network Analysis.
    Li R; Han K; Xu D; Chen X; Lan S; Liao Y; Sun S; Rao S
    Front Genet; 2020; 11():625977. PubMed ID: 33584817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Prognostic Signature Composed of GPI, IL22RA1, CCT6A and SPOCK1 for Lung Adenocarcinoma Based on Bioinformatic Analysis of lncRNA-Mediated ceRNA Network and Sample Validation.
    Tang W; Lu Q; Zhu J; Zheng X; Fang N; Ji S; Lu F
    Front Oncol; 2022; 12():844691. PubMed ID: 35433415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Big data analysis identified a telomere-related signature predicting the prognosis and drug sensitivity in lung adenocarcinoma.
    Zhang W
    Medicine (Baltimore); 2023 Nov; 102(46):e35526. PubMed ID: 37986388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
    Zhou J; Wang X; Li Z; Jiang R
    Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Five Autophagy Subtype-Related Gene Expression Pattern for Improving the Prognosis of Lung Adenocarcinoma.
    Zhang MY; Huo C; Liu JY; Shi ZE; Zhang WD; Qu JJ; Yue YL; Qu YQ
    Front Cell Dev Biol; 2021; 9():756911. PubMed ID: 34869345
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of the pyroptosis‑related prognostic gene signature and the associated regulation axis in lung adenocarcinoma.
    Lin W; Chen Y; Wu B; Chen Y; Li Z
    Cell Death Discov; 2021 Jun; 7(1):161. PubMed ID: 34226539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma.
    Li Z; Wang W; Wu J; Ye X
    Front Med (Lausanne); 2022; 9():962972. PubMed ID: 36091687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
    Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
    Front Immunol; 2022; 13():950001. PubMed ID: 36091041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
    Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
    Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis to identify a novel PTEN-associated ceRNA regulatory network as a prognostic biomarker for lung adenocarcinoma.
    Xin R; Shen B; Jiang YJ; Liu JB; Li S; Hou LK; Wu W; Jia CY; Wu CY; Fu D; Ma YS; Jiang GX
    Front Oncol; 2022; 12():923026. PubMed ID: 36091160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Analysis and Validation of the Prognosis, Immunological Role and Biology Function of the Ferroptosis-Related lncRNA GSEC/miRNA-101-3p/CISD1 Axis in Lung Adenocarcinoma.
    Jiang X; Yuan Y; Tang L; Wang J; Zhang D; Duan L
    Front Mol Biosci; 2021; 8():793732. PubMed ID: 35320929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of the molecular subtype and prognostic signature for clear cell renal cell carcinoma based on neutrophil extracellular traps.
    Quan J; Huang B
    Front Cell Dev Biol; 2022; 10():1021690. PubMed ID: 36523511
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioinformatics Identification and Validation of Aging‑Related Molecular Subtype and Prognostic Signature in Sarcoma.
    Hong X; Liu H; Chen C; Lai T; Lin J
    Cancer Invest; 2023 May; 41(5):512-523. PubMed ID: 37130077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma.
    Duan J; Lei Y; Lv G; Liu Y; Zhao W; Yang Q; Su X; Song Z; Lu L; Shi Y
    PeerJ; 2021; 9():e11074. PubMed ID: 33976960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.